large lesions can be laparoscopic management of left sided lesions. This aim of this study is to assess the impact of size on the feasibility and safety of lesions in the left pancreas. Methods: A retrospective collected database of patient undergoing LLP between June 2007 and June 2015 was reviewed. Data was divided into 2 groups according the size of the lesion, group A lesions >5 cm and group B lesions >5 cm. Results: A total of 105 LDP were performed. There were 73 patients (69.5%) in group A (mean size: 26.9 mm) and 32 patients (30.5%) in group B (mean size: 76.42 mm).The two groups were similar in Operation time (p = 0.662), blood loss (p = 0.728), length of stay (p = 0.586), length of specimen (p = 0.77) and post operative complications (p = 0.53). Large tumours showed higher conversion rate 0% vs 6.2% (p = 0.009). Conclusion: LDP for Large lesions is feasible and safe. However a higher conversion rate should be expected.
Background and rationale: Laparoscopic common bile duct exploration (LCBDE) is an established option for treating CBDS. The aim of this paper was to look at the feasibility of LCBDE and choledochoduodenostomy as a salvage procedure after failed endoscopic bile duct stone extraction, complicated bile duct stones and primary CBD strictures. Method: We retrospectively reviewed a prospective database, to study the feasibility of LCBDE with choledochoduodenostomy as salvage procedure for failed ERCP and complicated bile duct stones. Result: In our Institution from period of Jan 2013 to June 2015 total number of ERCP done for CBD stones was (n1) = 516 out of which failed ERCP account to (n2) = 24.24 patients who failed endoscopic stone extraction due to multiple large CBD calculi (12), recurrent stones (5), lower CBD stricture (4), impacted primary CBD stone (2), periampullary diverticulum (1). These patients underwent LCBDE and choledochoduodenostomy, of which 24 achieved successful stone clearance. Average operating time was 130 minutes and average blood loss was 50 ml. Stone clearance was done using direct choledochotomy in 6 patients, Dormia basket was used in 5 patients and balloon extraction was done in 3 patients. Stone clearance was confirmed with either choledochoscope or intraoperative cholangiogram in all patients. One patient developed bile leak which resolved spontaneously. The median length of stay for these 16 patients was five days. Conclusion: Laparoscopic common bile duct exploration with choledochoduodenostomy has been shown to be safe and effective method for treating complex CBDS with failed ERCP procedures.
discharge, and discharge destination were analyzed. Readmission rates at 30 days were analyzed using multivariate logistic regression models. Results: 2,202 patients met inclusion criteria. Median age was 74, 50.5% male. Readmission was 10.8% at 30 days. Demographics, Charlson comorbidity score, and education were not associated with readmission. LOS>10d was associated with increased readmission (OR = 1.73 [1.14,2.62]). Patients discharged to home had a decreased risk of readmission (OR = 0.55 [0.39,0.79]). Conclusions: This study represents preliminary work in examining readmission after treatment of colorectal liver metastases. Prolonged LOS and discharge to a non-home location carry an increased risk of readmission. Comorbidities and other patient factors did not influence readmission rate in the SEER-Medicare dataset, suggesting that standard demographic-based risk stratification may not be valid in this dataset. Additional research is needed to further elucidate and accurately predict causes of readmission.
At a median follow up of 12 months (range 10e17) one of the DHOPE preserved livers had developed non-anastomotic biliary strictures (NAS). In contrast, incidence of early NAS was 30% in controls (p = 0.372). Conclusion:This first clinical study of end-ischemic DHOPE in DCD liver transplantation demonstrates that this technique is safe, can restore cellular energy levels, and reduce reperfusion injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.